Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Stem Cells Translational Medicine|April 17, 2014
Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrityClara Steichen, Eléanor Luce, Jérôme Maluenda, et al.Neuromuscular Disorders : NMD|September 24, 2023
An early onset benign myopathy with glycogen storage caused by a de novo 1.4 Mb-deletion of chromosome 14Gianmarco Severa, Alessandra Pennisi, Christine Barnerias, et al.Biochemical and Biophysical Research Communications|March 19, 2018
Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cellsSandrine Girerd, Lucie Tosca, Olivier Herault, et al.Blood|January 4, 2019
Disrupted filamin A/α<sub>IIb</sub>β<sub>3</sub> interaction induces macrothrombocytopenia by increasing RhoA activityAlessandro Donada, Nathalie Balayn, Dominika Sliwa, et al.European Heart Journal|May 20, 2014
Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experiencePhilippe Menasché, Valérie Vanneaux, Jean-Roch Fabreguettes, et al.European Heart Journal|May 21, 2015
Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case reportPhilippe Menasché, Valérie Vanneaux, Albert Hagège, et al.Cytotherapy|April 23, 2013
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpointsLisbeth Barkholt, Egbert Flory, Veronika Jekerle, et al.Journal of the American College of Cardiology|February 2, 2018
Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular DysfunctionPhilippe Menasché, Valérie Vanneaux, Albert Hagège, et al.European Journal of Neurology|April 22, 2025
TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023Abd El Kader Ait Tayeb, Pauline Chazelas, Vianney Poinsignon, et al.Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.Pageof 7